Investing Ideas
/
Australian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Australian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

27 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NEU Neuren Pharmaceuticals	AU$13.41	2.8%	-33.4%	AU$1.7b	AU$27.00	PE14.5x	E-22.9%	n/a
CU6 Clarity Pharmaceuticals	AU$3.41	-2.6%	27.2%	AU$1.1b	AU$8.67	PS95.2x	E37.4%	n/a
PYC PYC Therapeutics	AU$1.30	-2.3%	64.6%	AU$606.6m	AU$3.40	PS27.5x	E33.0%	n/a
CUV Clinuvel Pharmaceuticals	AU$11.12	-0.8%	-31.7%	AU$555.4m	AU$28.23	PE15.6x	E26.2%	0.4%
IMM Immutep	AU$0.33	1.5%	-7.0%	AU$480.3m	AU$1.13	PS125x	E1.0%	n/a
IMU Imugene	AU$0.039	5.4%	-64.5%	AU$290.8m	AU$0.24	PS58.5x	E22.6%	n/a
DXB Dimerix	AU$0.48	-7.6%	136.6%	AU$270.8m	AU$0.84	PS464.1x	n/a	n/a
PAR Paradigm Biopharmaceuticals	AU$0.54	8.0%	56.5%	AU$210.3m	AU$0.92	PB8.8x	E-15.2%	n/a
RAC Race Oncology	AU$1.21	-4.0%	54.5%	AU$209.3m	AU$6.37	PS52.3x	E0.1%	n/a
ALA Arovella Therapeutics	AU$0.20	0%	11.4%	AU$206.6m	AU$0.33	PS105.8x	E47.2%	n/a
SNT Syntara	AU$0.087	22.5%	262.5%	AU$137.4m	AU$0.16	PS23.8x	E25.3%	n/a
TRJ Trajan Group Holdings	AU$0.76	-5.6%	-29.6%	AU$115.8m	AU$1.45	PS0.7x	E98.8%	n/a
GSS Genetic Signatures	AU$0.49	-9.3%	-3.0%	AU$111.3m	AU$1.05	PS8.1x	E74.5%	n/a
RCE Recce Pharmaceuticals	AU$0.44	1.1%	-7.9%	AU$102.0m	AU$2.46	PS20.3x	E18.3%	n/a
EZZ EZZ Life Science Holdings	AU$1.95	6.6%	302.1%	AU$92.0m	AU$5.45	PE13.2x	E17.9%	1.5%
VFY Vitrafy Life Sciences	AU$1.40	-3.4%	n/a	AU$89.4m	AU$2.15	PB2.6x	E60.9%	n/a
MVP Medical Developments International	AU$0.77	-1.3%	-22.7%	AU$86.2m	AU$3.33	PS2.6x	E91.2%	0%
NUZ Neurizon Therapeutics	AU$0.14	3.6%	-39.6%	AU$71.4m	AU$0.56	PS47.1x	S63.6%	n/a
RAD Radiopharm Theranostics	AU$0.024	0%	-57.9%	AU$56.0m	AU$0.25	PS28.6x	E44.1%	n/a
ATH Alterity Therapeutics	AU$0.01	-9.1%	100.0%	AU$54.9m	AU$0.036	PS13.7x	E-20.4%	n/a
CYP Cynata Therapeutics	AU$0.24	-8.6%	41.2%	AU$54.1m	AU$0.83	PS23.3x	E72.9%	n/a
BDX BCAL Diagnostics	AU$0.12	16.2%	27.8%	AU$42.1m	AU$0.20	PS13.6x	E90.6%	n/a
PTX Prescient Therapeutics	AU$0.047	-7.8%	4.4%	AU$37.9m	AU$0.14	PS10.2x	n/a	n/a
ILA Island Pharmaceuticals	AU$0.13	-7.4%	50.6%	AU$22.7m	AU$0.26	PS18.1x	E4.1%	n/a

Page 1 of 2